Brivanib structure, CAS 649735-46-6

Brivanib

CAS Number649735-46-6

SynonymsBrivanib; bms-540215

Molecular FormulaC19H19FN4O3

Molecular Weight370.38

Purity≥98 (HPLC)%

Density1.4±0.1 g/cm3

Boiling Point

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9057792 Purity: ≥98 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 649735-46-6 ] Purity: ≥98 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number649735-46-6
Catalog No.2A-9057792
Chinese Name布立尼布
SynonymsBrivanib; bms-540215
Molecular FormulaC19H19FN4O3
Molecular Weight370.38
Purity≥98 (HPLC)
Density1.4±0.1 g/cm3
Appearancepowder
Storage Conditionroom temperature
ApplicationBrivanib is an ATP-competitive VEGFR2 inhibitor with an IC50 value of 25 nM; it can moderately inhibit VEGFR-1 and FGFR-1, and its selectivity for VEGFR2 is 240 times higher than that for PDGFR-β.
HTC2933990090
MDL NumberMFCD13194684
SMILESFc1c2c([nH]c(c2)C)ccc1Oc3ncn[n]4c3c(c(c4)OC[C@H](O)C)C
InChI1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1
InChI KeyWCWUXEGQKLTGDX-LLVKDONJSA-N
NACRES CodeNA.25
UNSPSC12352200
MSDSmsds/57792_1_649735_46_6.pdf
Use ofBrivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Properties Name (2R)-1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]propanol Synonym More Synonyms Brivanib (BMS-540215) Biological Activity Description Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Related Catalog Signaling Pathways >> Autophagy >> Autophagy Research Areas >> Cancer VEGFR2:25 nM (IC50) References [1]. Bhide RS, et al. Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor. J Med Chem, 2006, 49 (7), 2143-2146. [2]. Huynh H, et al. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clin Cancer Res, 2008, [3]. Nakamura I, et al. Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. PLoS One. 2015 Nov 3;10(11):e0142355. Chemical & Physical Properties Molecular Formula C19H19FN4O3 Exact Mass 370.144104 PSA 84.67000 Index of Refraction 1.661 InChIKey WCWUXEGQKLTGDX-LLVKDONJSA-N Safety Information Hazard Codes Xi HS Code 2933990090 Synthetic Route 4-[(4-fluoro-2-... CAS#:649735-41-1 (R)-(+)-Propyle... CAS#:15448-47-2 Brivanib (BMS-5... CAS#:649735-46-6 Literature: Journal of Medicinal Chemistry, , vol. 51, # 6 p. 1976 - 1980 4-Fluoro-5-hydr... CAS#:288385-88-6 Brivanib (BMS-5... CAS#:649735-46-6 Literature: Journal of Medicinal Chemistry, , vol. 49, # 7 p. 2143 - 2146 5-methyl-4-phen... CAS#:310444-84-9 Brivanib (BMS-5... CAS#:649735-46-6 Literature: Journal of Medicinal Chemistry, , vol. 49, # 7 p. 2143 - 2146 Precursor & DownStream Precursor 8 CAS#:649735-41-1 4-[(4-fluoro-2-... CAS#:15448-47-2 (R)-(+)-Propyle... CAS#:288385-88-6 4-Fluoro-5-hydr... CAS#:310444-84-9 5-methyl-4-phen... DownStream 0
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA